secwatch.observer — SEC 8-K summary
======================================

Issuer:     PSYCHEMEDICS CORP (PMDI)
CIK:        0000806517
Form:       8-K
Filed at:   2022-08-09T23:59:59+00:00
Accession:  0001171843-22-005542
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Psychemedics Q2 2022 revenue up 7% to $6.5M; net loss $0.3M vs net income $0.1M YoY
--------------------------------------------------------------------------------

- Revenue $6.5M for Q2 2022, up 7% from $6.1M in Q2 2021; domestic revenue up 13% but Brazil down 65%.
- Net loss of $0.3M ($0.06 diluted EPS) vs net income of $0.1M ($0.02 EPS) YoY; prior-year quarter had $0.8M ERC benefit.
- Declared quarterly dividend of $0.07/share, payable Sept 9, 2022 to holders of record Aug 24, 2022.
- Cash $1.8M and working capital $5.6M as of June 30, 2022; equipment financing down to $0.9M from $12.2M borrowed.
- Continuing review of strategic alternatives; no assurance of any transaction or outcome.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/806517/000117184322005542/0001171843-22-005542-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/806517/000117184322005542/f8k_080922.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-005542

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer